Here are 11 orthopedic and spine device companies that received financing during 2012. If you would like to add a company to this list, please contact Laura at lmiller@beckershealthcare.com. AxioMed, a spinal orthopedics company, raised $5 million to complete its Series D financing that supports its Freedom Lumbar Disc, currently on the European market and advancing toward completion of the investigational device exemption study in the U.S.
Benvenue Medical System, a developer of minimally invasive solutions for spine repair, completed a $25 million Series D round of financing to sustain global commercialization of its three products and bring its fusion and VCF products to the U.S. market.
Cayenne Medical, a sports medicine device company, closed $10 million equity financing with Fletcher Spaght Ventures to support the company’s sales and distribution team and expand its product portfolio.
Cerapedics has received $19 million private equity financing from new investors, which will support the company’s activities with the ongoing clinical trial of the i-FACTOR peptide enhanced bone graft for cervical spine surgery.
ConforMIS, a Burlington, Mass.-based medical device company focused on personalized knee replacement implants, raised $89 million in Series E round funding with the potential for more in the future to support ongoing sales and marketing expansion, research and development of new product line as well as the building out of manufacturing infrastructure.
IlluminOss Medical, a photodynamic orthopedic implants manufacturer, secured $28 million in Series C round of venture capital financing as it pursues the minimally invasive IlluminOss Photodynamic Bone Stabilization System to treat fractures through a small entry into the bone.
Interventional Spine raised $1.6 million after receiving FDA approval for its PerX360 system for spinal fusion.
Lanx raised $8.7 million toward its target of $15.1 million to boost sales of the Timberline Lateral Fusion System and introduce four to six new products in 2013.
Mazor Robotic entered into a financing agreement for $15 million from a group of institutional and accredited investors led by Oracle Investment Management to further investment capital and facilitate the company’s efforts to implement an American Depositary Receipt program on a U.S. stock exchange.
Minimus Spine has received $1 million in financing from 19 investors, which will support the company’s ozone injection technology to treat herniated discs. Minimus Spine also secured $520,000 angel financing to pursue certification of its spinal injection system.
Regentis Biomaterials, a company focused on developing proprietary hydrogels for tissue regeneration, raised $10 million in financing from new investors Royal DSM through its venturing subsidiary, Crossroad Fund, Medica Venture Partners, SCPVitalife and Technion Investment Opportunities Fund to establish a European presence and expand ongoing clinical efforts with GelrinC.
More Articles on Orthopedic Devices:
Smith & Nephew CFO to Resign
Recall Issued for Medtronic Infusion Pumps
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund
Benvenue Medical System, a developer of minimally invasive solutions for spine repair, completed a $25 million Series D round of financing to sustain global commercialization of its three products and bring its fusion and VCF products to the U.S. market.
Cayenne Medical, a sports medicine device company, closed $10 million equity financing with Fletcher Spaght Ventures to support the company’s sales and distribution team and expand its product portfolio.
Cerapedics has received $19 million private equity financing from new investors, which will support the company’s activities with the ongoing clinical trial of the i-FACTOR peptide enhanced bone graft for cervical spine surgery.
ConforMIS, a Burlington, Mass.-based medical device company focused on personalized knee replacement implants, raised $89 million in Series E round funding with the potential for more in the future to support ongoing sales and marketing expansion, research and development of new product line as well as the building out of manufacturing infrastructure.
IlluminOss Medical, a photodynamic orthopedic implants manufacturer, secured $28 million in Series C round of venture capital financing as it pursues the minimally invasive IlluminOss Photodynamic Bone Stabilization System to treat fractures through a small entry into the bone.
Interventional Spine raised $1.6 million after receiving FDA approval for its PerX360 system for spinal fusion.
Lanx raised $8.7 million toward its target of $15.1 million to boost sales of the Timberline Lateral Fusion System and introduce four to six new products in 2013.
Mazor Robotic entered into a financing agreement for $15 million from a group of institutional and accredited investors led by Oracle Investment Management to further investment capital and facilitate the company’s efforts to implement an American Depositary Receipt program on a U.S. stock exchange.
Minimus Spine has received $1 million in financing from 19 investors, which will support the company’s ozone injection technology to treat herniated discs. Minimus Spine also secured $520,000 angel financing to pursue certification of its spinal injection system.
Regentis Biomaterials, a company focused on developing proprietary hydrogels for tissue regeneration, raised $10 million in financing from new investors Royal DSM through its venturing subsidiary, Crossroad Fund, Medica Venture Partners, SCPVitalife and Technion Investment Opportunities Fund to establish a European presence and expand ongoing clinical efforts with GelrinC.
More Articles on Orthopedic Devices:
Smith & Nephew CFO to Resign
Recall Issued for Medtronic Infusion Pumps
Ohio Third Frontier Gives $3M to Medical Device Partnership Fund